P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ARTL | N/A | N/A | N/A | +68.28% |
ARTL Peer | N/A | N/A | N/A | +43.43% |
Pharmaceuticals: Major Industry | 24.5 | 16.8 | 0.3 | +51.31% |
Health Technology Sector | 32.6 | 21.3 | 0.5 | +30.80% |
S&P 500 Market | 31.1 | 28.1 | 1.1 | +97.11% |
Q2 2022 | Q3 2022 | Q-32768 -32768 | Q-32768 -32768 | |
---|---|---|---|---|
Mean Estimate | -$0.06 | -$0.06 | -$0.05 | -$0.05 |
Previous Mean | -$0.05 | -$0.06 | -$0.05 | N/A |
Standard Deviation | 0.01 | 0.01 | 0.01 | 0.01 |
Low Estimate | -$0.06 | -$0.06 | -$0.06 | -$0.06 |
High Estimate | -$0.05 | -$0.05 | -$0.04 | -$0.04 |